-Advertisement-
-Advertisement-
Industry News
![](https://ophthalmology360.com/wp-content/uploads/2022/02/AdobeStock_327354278-scaled.jpeg)
Harrow Acquires Santen’s Branded Ophthalmic Portfolio
Harrow announced the signing of agreements with affiliates of Santen Pharmaceutical Co to acquire certain U.S. and Canadian commercial rights for a range of branded eyecare products. The acquisition marks a significant milestone for Harrow, as it broadens the company's product portfolio and enhances its presence in the U.S. ophthalmic...
Read More-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
Contact Info
© 2024 Ophthalmology 360® is a trademark of International Healthcare Media, LLC. All rights Reserved